Displaying One Session

View
Berlin Hall Industry Satellite Symposium

TouchIME - Industry Satellite Symposium: Addressing ongoing clinical challenges: How do we optimize patient outcomes with CDK4/6 inhibition in HR+/HER2- breast cancer? (ID 38)

Date
03.05.2019
Time
18:30 - 19:30
Location
Berlin Hall
Chairs
  • Stephen R. Johnston (London, United Kingdom)
TouchIME - Industry Satellite Symposium: Addressing ongoing clinical challenges: How do we optimize patient outcomes with CDK4/6 inhibition in HR+/HER2- breast cancer? (ID 38) Industry Satellite Symposium

Introduction and welcome – where are we now? (ID 811)

Lecture Time
18:30 - 18:35
Speakers
  • Stephen R. Johnston (London, United Kingdom)
Session Name
TouchIME - Industry Satellite Symposium: Addressing ongoing clinical challenges: How do we optimize patient outcomes with CDK4/6 inhibition in HR+/HER2- breast cancer? (ID 38)
Location
Berlin Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
03.05.2019
Time
18:30 - 19:30
TouchIME - Industry Satellite Symposium: Addressing ongoing clinical challenges: How do we optimize patient outcomes with CDK4/6 inhibition in HR+/HER2- breast cancer? (ID 38) Industry Satellite Symposium

Challenge 1. How do we optimize patient selection and treatment sequencing for HR+/ HER2- advanced breast cancer therapy in the era of CDK4/6 inhibition? Presentation with panel discus (ID 813)

Lecture Time
18:35 - 18:45
Speakers
  • Nadia Harbeck (Munich, Germany)
Session Name
TouchIME - Industry Satellite Symposium: Addressing ongoing clinical challenges: How do we optimize patient outcomes with CDK4/6 inhibition in HR+/HER2- breast cancer? (ID 38)
Location
Berlin Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
03.05.2019
Time
18:30 - 19:30
TouchIME - Industry Satellite Symposium: Addressing ongoing clinical challenges: How do we optimize patient outcomes with CDK4/6 inhibition in HR+/HER2- breast cancer? (ID 38) Industry Satellite Symposium

Challenge 2. How do we optimize AE management with CDK4/6 inhibitors? Presentation with panel discussion. Questions from the audience (ID 812)

Lecture Time
18:45 - 18:55
Speakers
  • Mario Campone (Saint-Herblain, CEDEX, France)
Session Name
TouchIME - Industry Satellite Symposium: Addressing ongoing clinical challenges: How do we optimize patient outcomes with CDK4/6 inhibition in HR+/HER2- breast cancer? (ID 38)
Location
Berlin Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
03.05.2019
Time
18:30 - 19:30
TouchIME - Industry Satellite Symposium: Addressing ongoing clinical challenges: How do we optimize patient outcomes with CDK4/6 inhibition in HR+/HER2- breast cancer? (ID 38) Industry Satellite Symposium

Clinical challenges in action. What would you do in our interactive case scenarios? Interactive case studies with audience voting (ID 814)

Lecture Time
18:55 - 19:10
Speakers
  • Stephen R. Johnston (London, United Kingdom)
Session Name
TouchIME - Industry Satellite Symposium: Addressing ongoing clinical challenges: How do we optimize patient outcomes with CDK4/6 inhibition in HR+/HER2- breast cancer? (ID 38)
Location
Berlin Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
03.05.2019
Time
18:30 - 19:30
TouchIME - Industry Satellite Symposium: Addressing ongoing clinical challenges: How do we optimize patient outcomes with CDK4/6 inhibition in HR+/HER2- breast cancer? (ID 38) Industry Satellite Symposium

Moving forward in early breast cancer: Future application of CDK4/6 inhibitors? Presentation with panel discussion. Questions from the audience (ID 815)

Lecture Time
19:10 - 19:30
Session Name
TouchIME - Industry Satellite Symposium: Addressing ongoing clinical challenges: How do we optimize patient outcomes with CDK4/6 inhibition in HR+/HER2- breast cancer? (ID 38)
Location
Berlin Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
03.05.2019
Time
18:30 - 19:30
TouchIME - Industry Satellite Symposium: Addressing ongoing clinical challenges: How do we optimize patient outcomes with CDK4/6 inhibition in HR+/HER2- breast cancer? (ID 38) Industry Satellite Symposium

Summary from the Chair and meeting close (ID 816)

Lecture Time
19:30 - 19:30
Speakers
  • Stephen R. Johnston (London, United Kingdom)
Session Name
TouchIME - Industry Satellite Symposium: Addressing ongoing clinical challenges: How do we optimize patient outcomes with CDK4/6 inhibition in HR+/HER2- breast cancer? (ID 38)
Location
Berlin Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
03.05.2019
Time
18:30 - 19:30